Unlearn.AI: Unlearn Signs Multi-Year Collaboration with Merck KGaA, Darmstadt, Germany to Accelerate Immunology Trials using Twintelligent RCTs
Collaborators will leverage AI-generated Digital Twins to enable smaller, more efficient pivotal clinical trials. Unlearn, developer of the Twintelligent RCT, today announced that the company has